Pharmacogenetics of antipsychotics in schizophrenia

Thérapie
Alexandre Méary

Abstract

There are no objective criterion of choice between the various antipsychotic treatments available in schizophrenia today. The final aim of the pharmacogenetic study of the efficacy and the tolerance of these treatments is the individual optimization of the drug treatments. Research in progress did not make it possible yet to highlight criteria usable in daily clinical practice. The assessment of larger cohorts, genetically homogeneous and prospectively evaluated should in the future make it possible to better predict the response to the treatment in particular in term of tolerance, to highlight new therapeutic targets and to better understand the mechanism of action of the current treatments.

References

Sep 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·J L Waddington, H A Youssef
Jan 6, 1996·Lancet·D VojvodaC M Mazure
Jan 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·I MataR M Murray
Nov 28, 2001·Acta Psychiatrica Scandinavica·D J MüllerM Rietschel
Jun 14, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bernard LererFabio Macciardi
Dec 9, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lous J A E Doude van TroostwijkHenk-Jan Guchelaar
Oct 23, 2004·BMJ : British Medical Journal·Stephen Senn
Nov 27, 2004·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelH J Möller
Jan 27, 2005·The Journal of Clinical Psychiatry·Jose de LeonPeter J Wedlund
Feb 8, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gavin P ReynoldsZhiJun Zhang
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Nov 30, 2005·Psychiatric Genetics·Frank M TheisenJohannes Hebebrand
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Shitij KapurMing Li
Sep 20, 2006·Pharmacogenomics·Daniel J Müller, James L Kennedy
Sep 11, 2007·European Journal of Clinical Pharmacology·Magnhild HendsetEspen Molden
Dec 19, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·A MéaryP M Llorca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The Psychiatric Clinics of North America
Adriana FosterPeter Buckley
Clinical Chemistry and Laboratory Medicine : CCLM
Pierre E Wallemacq
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
J KirchheinerJ Brockmöller
© 2022 Meta ULC. All rights reserved